Helix BioPharma Corp. (HBPCF) Financials
HBPCF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| April 30, 2026 | 15.7 million | 4.9 million |
| Jan. 31, 2026 | 13.6 million | 2.3 million |
| Oct. 31, 2025 | 13.6 million | 2.1 million |
| July 31, 2025 | 13.5 million | 2.3 million |
HBPCF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| April 30, 2026 | -647753 | ? |
| Jan. 31, 2026 | -335217 | ? |
| Oct. 31, 2025 | -622186 | ? |
| July 31, 2025 | -722029 | ? |
HBPCF Net Income
No data available :(
HBPCF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| April 30, 2026 | 2.1 million | - | - |
| Jan. 31, 2026 | 22787 | - | - |
| Oct. 31, 2025 | 355423 | - | - |
| July 31, 2025 | 46672 | - | - |
HBPCF Shares Outstanding
HBPCF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| April 30, 2026 | - | 216407 | 290752 | - |
| Jan. 31, 2026 | - | 305077 | 195543 | - |
| Oct. 31, 2025 | - | 279057 | 383257 | - |
| July 31, 2025 | - | 366200 | 341068 | - |
HBPCF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| April 30, 2026 | - | 736 |
| Jan. 31, 2026 | - | 734 |
| Oct. 31, 2025 | - | 1017 |
| July 31, 2025 | - | 717 |
HBPCF
Price: $1.71
52 week price:
Earnings Per Share: -0.03 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 130.6 million